Expanding the Pool in Orthotopic Heart Transplantation
NCT03222531
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Hepatitis C
Heart Transplant
Cardiac Transplant
Interventions
DRUG:
sofosbuvir/velpatasvir
Sponsor
Mary E. Keebler, MD